Posted by Michael Wonder on 15 Jun 2017
Cancer patients, children, and people with HIV amongst those to benefit from PHARMAC decisions
15 June 2017 - PHARMAC has announced the funding of five new treatments and wider use of over 30 existing treatments, which are set to benefit many New Zealanders from 1 July 2017.
PHARMAC helps New Zealanders live healthier and better lives every day, and this package of medicines is set to help a lot of New Zealanders get the medicines they need, says Sarah Fitt, PHARMAC Director of Operations.
The package covers a wide range of medicines, including new cancer treatments bendamustine hydrochloride for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma, medicines for children, and widened access to treatments for HIV and hepatitis C.
